In breast tumor tissues of the curcumin-treated group, a significant suppression of NF-κB p65 and a deregulation of NF-κB-related genes expression, cyclin D1, and PECAM-1 were detected [126]. The gene discussed is NFKB1; the disease is breast neoplasm.